UW Lab members head to Kisumu, Kenya to train colleagues on the plasmodium 18S rRNA RT-PCR assay in support of clinical trials in kenya
Mariko Seilie and Amelia Hanron are in Kisumu, Kenya this week to work with colleagues at the KEMRI-CDC site. The UW team will formally train our Kenyan colleagues on the UW-developed Plasmodium 18S rRNA biomarker RT-PCR assay that is used as a infection detection tool in malaria clinical trials. This site is the first facility in a malaria-endemic country to bring up the biomarker assay. The UW and KEMRI-CDC anticipate that this collaboration will enhance the ability to conduct clinical trials in the Kisumu region, including at the main field site in Siaya. The UW and Kisumu sites will be able to exchange materials, provide quality assurance for one another and eventually lead the development of a larger multi-center network equipped to run the molecular malaria assays.